Study Group: Biopharmaceuticals Manufacturers (US)
Council Members in this Study Group: 43
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Contact Gerson Lehrman Group to survey or consult with members of this Study Group
Leading institutions connect with members of this Study Group through GLG
Leading Experts in this Study Group
Vasilios VoudourisChief Executive Officer
Vereniki Solutions
Vasilios Voudouris is Chief Executive Officer of Vereniki Solutions, a consultancy supporting the biotech/pharma industry. Previously, he led process engineering at Nektar, where he validated Exubera for commercialization. He also was an Executive Director...
Hany SalamaVice President, Worldwide Operations
NEOSTRATA COMPANY, INC.Hany Salama, ME, MBA, CPM, CPSM, is the Vice President, Worldwide Operations at The NeoStrata Company. He has global responsibilities for commercial planning, supply chain, strategy, and distribution/manufacturing operations for all global marketed products....
Eric GruffPrincipal
E4 ConsultingEric Gruff, PhD, MBA, BS, is the Founder of E4 Consulting, which specializes in pharmaceutical development, regulatory affairs, and project and portfolio management. Dr. Gruff has 19 years of experience in the pharmaceutical and biotech sector, including...
- Leo Pavliv
Senior Vice President, Operations
CUMBERLAND PHARMACEUTICALS, INC.Leo Pavliv, RPh, MBA, is a Senior Vice President of Operations at Cumberland Pharmaceuticals in Tennessee. His job responsibilities include directing overall drug development activities for numerous products, regulatory affairs, product development, clinical...
Peter CulpepperChief Financial Officer
Provectus Pharmaceuticals, Inc.Peter Culpepper is the Chief Financial Officer and Chief Operating Officer at Provectus Pharmaceuticals. Mr. Culpepper has experience in prescription (therapeutic), biotech, healthcare OTC, specialty pharma, and medical device products. Previous to that,...
Members in this Study Group include these company types:
- Biotechnology Manufacturer
- Pharmaceuticals Manufacturer
- Consultancy, Pharma-Focused
- Pharmaceuticals/Biotechnology Research Services
- Medical Device Manufacturer
Members in this Study Group often have these job titles:
- Director
- President
- Chief Executive Officer
- Chief Medical Officer
- Owner
- Chief Financial Officer
- Consultant
- Manufacturing Director
- Research & Development Manager
- Operations Executive
Related Study Groups
Gerson Lehrman Group, Inc. connects communities with knowledge through two distinct, yet complementary offerings: GLG Research and G+.